Comment and response to: dapagliflozin - do we need it registered for type 2 diabetes?

Expert Opin Pharmacother. 2014 Dec;15(18):2751-2. doi: 10.1517/14656566.2014.974897. Epub 2014 Oct 27.

Author

Serge Jabbour¹

Affiliation

¹ Jefferson Medical College of Thomas Jefferson University, Department of Medicine, Division of Endocrinology, Diabetes, and Metabolic Diseases , Philadelphia, PA 19107 , USA +1 215 955 1925 ; +1 215 928 3160 ; serge.jabbour@jefferson.edu.

PMID: 25346092
DOI: 10.1517/14656566.2014.974897

No abstract available

Publication types

Letter
Comment

MeSH terms

Benzhydryl Compounds / administration & dosage*
Diabetes Mellitus, Type 2 / drug therapy*
Female
Glucosides / administration & dosage*
Humans
Hypoglycemic Agents / administration & dosage*
Male
Metformin / administration & dosage*
Pyrazines / administration & dosage*
Triazoles / administration & dosage*

Substances

Benzhydryl Compounds
Glucosides
Hypoglycemic Agents
Pyrazines
Triazoles
Metformin